Іздеу

Tactics of hypoglycemic treatment in patients with pancreatogenic diabetes: a prospective study

Nikulin I., Bagriy A., Mikhailichenko E., Kutya A., Sovpel Y.

(Rus)

Том 30, № 3 (2023)

Glycemic variability diary as a tool for assessing the effectiveness of diabetes therapy. Clear and accessible. Case series

Smirnova E.

(Rus)

Том 30, № 3 (2023)

Modern practice of lipid-lowering pharmacotherapy: the choice of the optimal fixed combination

Biryukova E., Shinkin M., Morozova I.

(Rus)

Theory and practice of use of dipeptidyl peptidase-4 inhibitors: focus on evogliptin

Biryukova E.

(Rus)

Dipeptyl peptidase type 4 inhibitors for modern therapy of type 2 diabetes mellitus

Demidov N.

(Rus)

Metabolic effects of metformin in patients with type 2 diabetes mellitus and new coronavirus infection

Zhurtova I., Gubachikova A., Aramisova L., Anaeva L., Abdul Moati H.

(Rus)

The use of sodium-glucose co-transporter type II (SGLT2) inhibitors in patients with chronic heart failure against the background of type 2 diabetes mellitus

Petrov V., Shatalova O., Klykova M., Stetsky N.

(Rus)

Screening, diagnosis and treatment of early carbohydrate metabolism disorders

Demidova I., Boeva V.

(Rus)

Vildagliptin – 15 years in active service with diabetologists

Pavlova M.

(Rus)

Clinical case of achieving compensation for type 2 diabetes mellitus in preparation for pregnancy in a woman of reproductive age

Markina J.

(Rus)

Modern and safe treatment of type 2 diabetes mellitus. Clinical case of the use of gozogliptin in the treatment of a patient with decompensated diabetes mellitus

Smirnova E.

(Rus)

How to improve the quality of type 2 diabetes mellitus management in routine clinical practice. experience of using a glycemic variability diary

Astamirova K., Gatina A., Gorbunova Y., Demidov N., Ivanenko T., Kolesnikova M., Lapteva O., Morozova I., Parshina V., Presnyakova O., Smirnova E., Smirnova N., Startseva M., Khamrazhanov Z., Kholmskaya N.

(Rus)

Analysis of the quality of clinical follow-up care of patients with type 2 diabetes mellitus

Demicheva T.

(Rus)

Possibilities of using a fixed combination of alogliptin and pioglitazone in patients with type 2 diabetes mellitus in everyday clinical practice

Elsukova O., Nikitina E., Chuprova A., Kaysina O.

(Rus)

Glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes mellitus: how to choose the right solution

Antsiferov M., Koteshkova O., Antsiferova D., Demidov N.

(Rus)

The use of dulaglutide in real clinical practice in patients with type 2 diabetes mellitus in Moscow

Antsiferov M., Antsiferova D., Koteshkova O., Demidov N.

(Rus)

Experience with the use of valsartan/sacubitril in patients with chronic heart failure in combination with type 2 diabetes mellitus and paroxysmal atrial fibrillation

Ignatenko A., Bagriy A., Prikolota A., Prikolota O., Mikhailichenko E., Golodnikov I., Bagriy O.

(Rus)

Modern possibilities for assessing glycemia in diabetic patients

Chernikova N., Degtyareva E.

(Rus)

№ 20 (2014)

Obespechennost' vitaminom D i metabolicheskie narusheniya: sistematicheskiy analiz fundamental'nykh i dokazatel'nykh issledovaniy po problemam izbytochnoy massy tela i sakharnogo diabeta

Gromova O., Torshin I., Limanova O., Grishina T., Gromov A.

(Rus)

Том 28, № 4 (2021)

Modern drug approaches to glycemic control in patients with type 1 and 2 diabetes mellitus

Bagriy A., Shchukina E., Efremenko V., Mikhailichenko E., Suprun E.

(Rus)

News of medicine

Kudinova S.

(Rus)

Том 28, № 4 (2021)

Practical aspects of the use of semaglutide (Ozempic®) in real clinical practice

Antsiferov M., Zilov A., Koteshkova O., Demidov N.

(Rus)

Том 29, № 4 (2022)

Type 3 diabetes mellitus: is there a chance to become famous?

Morgunov L.

(Rus)

№ 3 (2012)

SITAGLIPTIN: CURRENT POSITIONS AND PROSPECTS FOR THERAPY OF TYPE 2 DIABETES MELLITUS

Druk I., Nechaeva G., Korennova O., Druk I., Nechayeva G., Korennova O.

№ 3 (2012)

DIABETES IN CHILDREN AND ADOLESCENTS: TO THE 90TH ANNIVERSARY OF THE INTRODUCTION OF INSULIN IN CLINICAL PRACTICE

Peterkova V., Peterkova V.

№ 10 (2012)

Rol' terapevticheskogo obucheniya patsientov na pompovoy insulinoterapii

Ametov A., Valitov B., Chernikova N., Antsiferov M.

(Rus)

№ 5 (2017)

PATHOPHYSIOLOGICAL APPROACH AS A BASIS FOR THE SELECTION OF STRATEGY FOR THE SUCCESS TREATMENT OF TYPE 2 DIABETES MELLITUS

Ametov A.

(Rus)

№ 5 (2013)

SODERZhANIE VITAMINA D 3 I POKAZATELI METABOLIZMA KOSTNOY TKANI U ZhENShchIN S SAKhARNYM DIABETOM 2 TIPA

Verbovoy A., Sharonova L., Verbovaya N., Demidova D., Kapishnikov A.

(Rus)

Том 28, № 4 (2021)

Ipragliflozin in the treatment of comorbid patients with type 2 diabetes mellitus

Chernikova N., Knyshenko O., Ivanova L.

(Rus)

№ 11 (2012)

Algoritmy spetsializirovannoy meditsinskoy pomoshchi bol'nym sakharnym diabetom 2011 g.: osnovnye izmeneniya

Mayorov A.

(Rus)

№ 5 (2015)

Ingibitory SGLT-2: farmakologicheskaya glyukozuriya kak novyy podkhod v upravlenii SD 2 tipa

Demidova T.

(Rus)

№ 5 (2017)

CURRENT POSSIBILITIES OF COMBINED THERAPY IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS

Chemikova N.

(Rus)

Том 27, № 4 (2020)

Does autoimmune thyroiditis affect the clinical course of type 1 diabetes mellitus in children, regardless of the functional state of the thyroid gland?

Abdullaev A., Litvinova D., Rozhkov N., Kiyaev A.

(Rus)

№ 16 (2010)

SAXAGLIPTIN OPENS NEW OPPORTUNITIES FOR EFFECTIVE AND SAFE GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Mkrtumyan A., Mkrtumyan A.

Possibilities of dapagliflozin in cardio-reno-metabolic protection in patients with and without type 2 diabetes mellitus

Antsiferov M., Koteshkova O., Novikova M., Demidov N.

(Rus)

№ 16 (2013)

Novyy klass antidiabeticheskikh preparatov - ingibitory natriy-glyukoznykh kotransporterov

Ushkalova E.

(Rus)

Is non-alcoholic fatty liver disease a consequence of obesity and a predictor of diabetes?

Volkova N., Panenko S., Golubeva A.

(Rus)

Том 28, № 3 (2021)

The choice of antianginal therapy for polymordib patients with coronary artery disease and type 2 diabetes mellitus: the benefits of trimetazidine

Kochetkov A., Pereverzev A., Ostroumova O., Gusenbekova D., Romanovsky R., Shatalova N.

(Rus)

Effect of Subetta on glycemic control in patients with type 2 diabetes mellitus: results of a multicenter, double-blind, placebo-controlled, randomized clinical study

Mkrtumyan A., Vorobyev S., Volkova A., Vorokhobina N.

(Rus)

Том 26, № 14 (2019)

Early pathogenetic combined therapy of sugar diabetes type 2: focus on insulin resistance

Ametov A., Tertychnaya E.

(Rus)

The state of carbohydrate metabolism and the development of cerebrovascular diseases in patients with type 2 diabetes mellitus

Antonova K., Tanashyan M., Maksimova M., Shakhparonova N., Romantsova T.

(Rus)

№ 4 (2018)

ASSESSMENT OF THE EFFICACY AND SAFETY OF INSULIN DEGLUDEC IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS IN REAL-LIFE CLINICAL PRACTICE

Kiyaev A., Kondrashova O., Chernykh L., Pollyak O., Yusupova A., Slovak M., Zaykova I.

(Rus)

№ 16 (2017)

Diabetic distal polyneuropathy: the principles of diagnostics and therapy

Komelyagina E., Antsiferov M.

(Rus)

№ 5 (2017)

SAFE AND EFFECTIVE COMBINATION OF ULTRALONG-ACTING BASAL INSULIN DEGLUDEC AND ULTRA-SHORT ACTING INSULINE ASPART IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS

Girsh Y., Veliyeva O.

(Rus)

№ 16 (2016)

Current approaches to therapy of type 2 diabetes mellitus in the era of new data on cardiovascular safety

Antsiferov M., Schernthaner G.

(Rus)

№ 17 (2015)

Adipokiny i gormonal'no-metabolicheskie pokazateli u bol'nykh sakharnym diabetom 2 tipa i podagroy

Verbovoy A., Tsanava I., Verbovaya N.

(Rus)

№ 5 (2015)

Preimushchestva fiksirovannoy kombinatsii saksagliptina i metformina modifitsirovannogo vysvobozhdeniya (Kombogliz Prolong) v terapii SD 2 tipa

Ametov A.

(Rus)

№ 16 (2014)

Issledovanie ORIGIN (Outcome Reduction with Initial Glargine INtervention) 2 goda spustya: chto novogo?

Glinkina I.

(Rus)

№ 16 (2013)

Rol' i mesto gipoglikemii v upravlenii sakharnym diabetom 2 tipa

Chernikova N., Antsiferov M.

(Rus)

№ 16 (2012)

Ratsional'naya farmakoterapiya SD 2 tipa: primenenie ingibitora DPP-4 saksagliptina i metformina v klinicheskoy praktike

Ametov A., Brashchenkova A.

(Rus)

№ 3 (2012)

PLACE OF DIBCOR® IN THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS AND METABOLIC SYNDROME

Vorokhobina N., Kuznetsova A., Vorohobina N., Kuznetsova A.

№ 5 (2011)

CLINICAL AND METABOLIC EFFICIENCY OF DRUG DIBIKOR IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Severina T., Popkova E., Trel'skaya N., Emel'yanov V., Severina T., Popkova Y., Trelskaya N., Yemelyanov V.

№ 16 (2010)

POSSIBILITY OF CORRECTION OF OXIDATIVE STRESS IN PATIENTS WITH DIABETES USING DIBICOR

Zanozina O., Zanozina O.

№ 16 (2010)

POTENTIALS FOR USE OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN TYPE 2 DIABETES MELLITUS: INITIATION AND CONTINUATION OF THERAPY

Antsiferov M., Zilov A., Antsiferov M., Zilov A.

Том 29, № 4 (2022)

Problem of treatment adherence in patients with type 2 diabetes mellitus

Akulova A., Zhulina Y., Rozhkova V., Martynova E., Poteshkin Y.

(Rus)

Combination of two hypoglycemic drugs for type 2 diabetes mellitus

Morgunova T., Fadeyev V.

(Rus)

Том 26, № 14 (2019)

Hypoglycemic drugs and drug-induced heart failure

Ostroumova O., Goloborodova I.

(Rus)

Hyperglycemia and ischemic stroke: clinical features in patients with type 2 diabetes mellitus

Izhbuldina G., Novikova L.

(Rus)

№ 11 (2018)

Problem of detection and pharmacological correction of anxious and depressive disorders in patients with type 2 diabetes mellitus

Sorokina Y., Zanozin A., Zanozina O., Runov G.

(Rus)

№ 4 (2018)

NEW POSSIBILITIES OF CARDIOVASCULAR RISK MANAGEMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Verbovoy A., Pashentseva A., Verbovaya N., Kosareva O.

(Rus)

№ 16 (2017)

Fixed-dose combinations in the therapy of type 2 diabetes mellitus: the way to achieving good glycemic control

Biryukova E.

(Rus)

№ 5 (2016)

POTENTIALS FOR THE IMPROVEMENT OF TREATMENT OF PATIENTS WITH TYPE 1 DIABETES MELLITUS USING HUMAN ULTRA-LONG INSULIN ANALOGUE DEGLUDEC IN OUTPATIENT SETTINGS

Kalashnikova M., Zilov A., Yazykova D., Likhodey N., Fadeev V.

(Rus)

№ 17 (2015)

Gipoglikemiya i kachestvo zhizni bol'nykh sakharnym diabetom 2 tipa

Antsiferov M., Nikitina T., Rodionova A., Kurbatova K., Ionova T.

(Rus)

№ 5 (2015)

Preimushchestva svoevremennoy initsiatsii insulinoterapii. Rezul'taty rossiyskoy observatsionnoy programmy HUBIN

Chernikova N., Ivanova L., Abaeva F.

(Rus)

№ 16 (2014)

Leptin i gormonal'no-metabolicheskie pokazateli u bol'nykh bronkhial'noy astmoy i pri ee sochetanii s sakharnym diabetom 2 tipa

Verbovoy A., Sharonova L., Akhmerova R.

(Rus)

№ 16 (2013)

Osobennosti terapii perenesennogo insul'ta u bol'nykh sakharnym diabetom

Shavlovskaya O.

(Rus)

№ 16 (2013)

Effektivnyy i bezopasnyy kontrol' glikemii s pomoshch'yu Diabetona MV: zalog uspeshnoy profilaktiki khronicheskikh oslozhneniy sakharnogo diabeta 2 tipa

Biryukova E., Danilova T.

(Rus)

№ 5 (2013)

INNOVATsIONNAYa SAKhAROSNIZhAYuShchAYa TERAPIYa: NOVAYa STRATEGIYa DLYa STAROY PROBLEMY

Antsiferov M., Schemthaner G., Ametov A.

(Rus)

№ 11 (2012)

Osobennosti lecheniya narusheniy tolerantnosti k glyukoze u patsientov s abdominal'no-vistseral'nym tipom ozhireniya na rannikh etapakh ego razvitiya

Shilov A., Abdullaeva A.

(Rus)

№ 3 (2012)

GLUCAGON-LIKE PEPTIDE-1: FROM PHYSIOLOGY TO EFFECTIVE MANAGEMENT OF TYPE 2 DIABETES MELLITUS

Antsiferov M., Antsiferov M.

№ 3 (2011)

RESULTS OF OBSERVATIONAL PROGRAM ON USE OF INSULIN GLARGINE (LANTUS®) IN COMBINATION WITH ORAL HYPOGLYCEMIC AGENTS FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS IN ROUTINE CLINICAL PRACTICE

Glinkina I., Romantsova T., Glinkina I., Romantsova T.

№ 16 (2010)

PHARMACOECONOMIC ASPECTS OF USE OF SULFONYLUREA MEDICATIONS IN INSULIN-INDEPENDENT DIABETES

Rudakova A., Rudakova A.

№ 3 (2010)

Advance - movement forward

Petunina N., Petunina N.

Том 29, № 11/12 (2022)

Place of GLP-1 receptor antagonists and SGLT-2 inhibitors in modern therapy of type 2 diabetes mellitus

Antsiferov M., Koteshkova O., Dukhareva O., Demidov N., Novikova M.

(Rus)

Carbohydrate metabolism disorders and osteoporosis

Alekseeva N.

(Rus)

The use of fixed ratio combination of insulin glargine and lixisenatide in patients with type 2 diabetes mellitus in real clinical practice. Own clinical experience

Khamnueva L., Andreeva L., Davydova A., Chugunova E., Tokareva N., Molodtsova N.

(Rus)

Experience of the use of insulin degludec in the treatment of patients with type 1 diabetes mellitus (according to the data of the Moscow segment of the Federal Diabetes Register)

Demidov N., Mishra O., Antsiferov M.

(Rus)

№ 4 (2018)

NEW ONCE-WEEKLY GLP-1 RECEPTOR AGONIST - A QUALITATIVE LEAP IN MANAGEMENT OF TYPE 2 DIABETES MELLITUS

Demidova T.

(Rus)

№ 6 (2017)

POTENTIALS FOR THE DRUG CORRECTION OF SECONDARY MITOCHONDRIAL DYSFUNCTION IN PATIENTS WITH CORONARY ARTERY DISEASE AND COMORBID PATHOLOGY

Statsenko M., Turkina S., Tyshchenko I., Fabritskaya S., Poletaeva L.

(Rus)

№ 5 (2016)

EFFICIENCY OF MULTICOMPONENT THERAPY IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS (CLINICAL CASE)

Koteshkova O., Molina L.

(Rus)

№ 17 (2015)

10 let ispol'zovaniya pompovoy insulinoterapii v moskovskoy pediatricheskoy praktike -

Rybkina I., Petryaykina E., Koltunov I.

(Rus)

№ 5 (2015)

Alogliptin - effektivnyy i bezopasnyy ingibitor dipeptidilpeptidazy-4 v terapii bol'nykh sakharnym diabetom 2 tipa

Mkrtumyan A.

(Rus)

№ 16 (2014)

Fiksirovannaya kombinatsiya saksagliptina i metformina modifitsirovannogo vysvobozhdeniya - novyy shag v uluchshenii priverzhennosti k lecheniyu sakharnogo diabeta 2 tipa

Biryukova E.

(Rus)

№ 16 (2013)

Upravlenie lipotoksichnost'yu v debyute sakharnogo diabeta 2 tipa

Ametov A., Tertychnaya E.

(Rus)

№ 5 (2013)

SOSTOYaNIE KOSTNOY TKANI PRI SAKhARNOM DIABETE 2 TIPA

Ruyatkina L., Lomova A., Ruyatkin D.

(Rus)

№ 3 (2012)

TIMELY ADMINISTRATION OF INSULIN THERAPY IN TYPE 2 DIABETES MELLITUS

Chernikova N., Prudnikova M., Chernikova N., Prudnikova M.

№ 16 (2011)

Galvus and Galvus Met in treatment of elderly patients with type 2 diabetes mellitu

Antsiferov M., Antciferov M.

№ 3 (2011)

CLINICAL ASPECTS FOR USE OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN COMBINATION WITH METFORMIN: BENEFITS FOR DIFFERENT GROUPS OF PATIENTS

Antsiferov M., Antsiferov M.

№ 16 (2010)

ROLE OF SPECIALIZED NUTRITION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: CLINICAL EXPERIENCE OF USING OF GLUCERNA SR

Antsiferov M., Morgunov L., Antsiferov M., Morgunov L.

№ 8 (2010)

ADIPONECTIN AND C-REACTIVE PROTEIN AS FACTORS OF CARDIOVASCULAR RISK IN MEN WITH TYPE 2 DIABETES MELLITUS

Morkovskikh N., Morkovskikh N.

№ 3 (2010)

Sulfonylurea drugs and risk of cardiovascular complications - much ado about nothing?

Nedosugova L., Nedosugova L.

Том 29, № 11/12 (2022)

Cardiovascular outcomes during treatment with dipeptidyl peptidase-4 inhibitors depending on renal function and combination with metformin: a systematic review

Petunina N., Martirosyan N., Valeeva F.

(Rus)

Obesity: an invisible disease

Verbovoy A., Dolgikh Y., Verbovaya N., Lomonova T.

(Rus)

Clinical experience of long-term observation of the efficacy of a fixed combination of insulin glargine and GLP-1RA lixisenatide in patients with type 2 diabetes mellitus who did not reach the target glycemia values with the use of oral antidiabetic drugs

Resolution on the results of the expert panel «IDegLira: is it 1 + 1 or anything more?»

Antsiferov M., Galstyan G.

(Rus)

Том 27, № 4 (2020)

Mkrtumyan A., Markova T.

(Rus)

Extreme risk category in the stratification of cardiovascular complications. Consensus Council of experts

Expert C.

(Rus)